Biol Reprod Lalor Postdoctoral Fellowships -- Application Deadline January 15, 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print May 28, 2003.
Biol Reprod 2003, 10.1095/biolreprod.102.014555
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
69/3/933    most recent
biolreprod.102.014555v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perotti, M.-E.
Right arrow Articles by Phillips, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perotti, M.-E.
Right arrow Articles by Phillips, D. M.
Agricola
Right arrow Articles by Perotti, M.-E.
Right arrow Articles by Phillips, D. M.
Submitted December 13, 2002
Returned for revision December 31, 2002
Accepted March 6, 2003

Female Reproductive Tract


Carrageenan Formulation Prevents Macrophage Trafficking from Vagina: Implications for Microbicide Development

Maria-Elisa Perotti , Alessia Pirovano , and David M. Phillips *

* To whom correspondence should be addressed. E-mail: dphillips{at}popcouncil.org.

Abstract

Considerable evidence suggests that HIV-infected macrophages and/or lymphocytes may mediate sexual transmission of HIV. Our laboratory and other laboratories have previously demonstrated that when vitally stained donor mouse lymphocytes or macrophages are placed in the vaginas of mice, some of the stained cells can later be found in the iliac lymph nodes. The aim of this study was to assess the extent of mononuclear cells trafficking from the vagina and to test the possibility that carrageenan formulation, a sulfated polysaccharide formulation containing 3% PDR98-15 carrageenan (FMC Biopolymer, Rockland ME - PC-515), a vaginal microbicide, would prevent vaginal transmigration of macrophages. When we inoculated supravitally stained mouse macrophages and T cells into the vagina of recipient mice, we observed that discrete numbers of donor?s cells migrated to the recipients? iliac and inguinal lymph nodes and to the spleen as well. When recipient mice were pre-inoculated with the carrageenan formulation, the number of macrophages in lymph nodes and spleen was reduced by greater than 90%. In contrast, a methylcellulose formulation, which is believed to be inactive, did not reduce migration to the lymphoid organs significantly. Our findings suggest that the carrageenan formulation blocks cell trafficking of macrophages from vagina and that blocking does not result from cytotoxicity. We speculate that blocking cell trafficking may help to prevent sexual transmission of HIV.



Key words: Female Reproductive Tract • Toxicology • Cervix • Ovulatory cycle • Vagina






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2003 by the Society for the Study of Reproduction.